Abrdn (ABDN) RNS Announcements

Add to Alert list
Date Time Source Announcement
19 May 2023 11:05 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
19 May 2023 11:04 AM
RNS
Form 8.3 - Industrials REIT Limited
18 May 2023 11:54 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
18 May 2023 11:54 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
17 May 2023 11:52 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
17 May 2023 11:50 AM
RNS
Form 8.3 - Industrials REIT Limited
16 May 2023 11:26 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
15 May 2023 11:50 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
15 May 2023 11:44 AM
RNS
Form 8.3 - John Wood Group plc
15 May 2023 11:44 AM
RNS
Form 8.3 - John Wood Group plc
12 May 2023 10:50 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
12 May 2023 10:41 AM
RNS
Form 8.3 - Industrials REIT Limited
11 May 2023 11:33 AM
RNS
Form 8.3 - John Wood Group plc
11 May 2023 11:25 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
11 May 2023 07:00 AM
RNS
Results of AGM & Board Changes
10 May 2023 11:53 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
09 May 2023 07:00 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
05 May 2023 10:49 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
05 May 2023 10:45 AM
RNS
Form 8.3 - John Wood Group plc
04 May 2023 11:08 AM
RNS
Form 8.3 - Industrials REIT Limited
04 May 2023 11:01 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
03 May 2023 02:49 PM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
02 May 2023 10:00 AM
RNS
Total Voting Rights
02 May 2023 07:00 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
02 May 2023 07:00 AM
RNS
Form 8.3 - Industrials REIT Limited
28 Apr 2023 11:03 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
27 Apr 2023 12:05 PM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
26 Apr 2023 03:28 PM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
26 Apr 2023 12:26 PM
RNS
Form 8.3 - John Wood Group plc
26 Apr 2023 12:26 PM
RNS
Form 8.3 - Industrials REIT Limited
25 Apr 2023 12:05 PM
RNS
Form 8.3 - Medica Group plc
25 Apr 2023 12:03 PM
RNS
Form 8.3 - Industrials REIT Ltd
25 Apr 2023 12:03 PM
RNS
Form 8.3 - Industrials REIT Ltd
25 Apr 2023 11:58 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
25 Apr 2023 11:58 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
25 Apr 2023 11:55 AM
RNS
Form 8.3 - John Wood Group plc
25 Apr 2023 11:55 AM
RNS
Form 8.3 - John Wood Group plc
24 Apr 2023 11:27 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
24 Apr 2023 11:27 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
24 Apr 2023 11:21 AM
RNS
Form 8.3 - Industrials REIT Limited
24 Apr 2023 11:21 AM
RNS
Form 8.3 - Industrials REIT Limited
24 Apr 2023 11:12 AM
RNS
Form 8.3 - John Wood Group plc
24 Apr 2023 11:12 AM
RNS
Form 8.3 - John Wood Group plc
21 Apr 2023 11:27 AM
RNS
Form 8.3 - John Wood Group plc
21 Apr 2023 11:27 AM
RNS
Form 8.3 - John Wood Group plc
21 Apr 2023 11:23 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
21 Apr 2023 11:23 AM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
20 Apr 2023 12:19 PM
RNS
Form 8.3 - John Wood Group plc
20 Apr 2023 12:17 PM
RNS
Form 8.3 - Dechra Pharmaceuticals PLC
20 Apr 2023 12:07 PM
RNS
Form 8.3 - Industrials REIT Limited

Abrdn plc, formerly Standard Life Aberdeen plc, is a United Kingdom-based global investment company headquartered in Edinburgh, Scotland. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

The Company's segments include Investments, Advisor and Other. The Company's Investment segment includes global asset management business, which provides investment solutions for Institutional, Retail Wealth and Insurance Partners clients.

Its UK financial adviser business provides platform services to wealth managers and advisers. Through its subsidiary Interactive Investor Services Limited, the Company offers a subscription-based trading and direct investing platform. The services that it offers are provided on both a point in time and an over time basis. It offers financial planning business, through abrdn Financial Planning and Advice. Its Other segment comprises of Finimize and its digital innovation group.

Founded in 1825, Abrdn share price launched at 273p in 2006.

UK 100

Latest directors dealings